Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: The first step in improving quality

Rheumatology

Volumn 50, Issue 2, 2011, Pages 366-372

  Desai, Sonali P ^a   Turchin, Alexander ^a   Szent Gyorgyi, Lara E ^a   Weinblatt, Michael ^a   Coblyn, Jonathan ^a   Solomon, Daniel H ^a   Kachalia, Allen ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Immunosuppression; Pneumococcal vaccination; Quality improvement; Quality measurement

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISOLONE; PREDNISONE; RITUXIMAB;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION; VASCULITIS;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OUTPATIENTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; QUALITY OF HEALTH CARE; RHEUMATIC DISEASES; UNITED STATES;

EID: 78951471787     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq297     Document Type: Article

References (33)

1. McGlynn EA, Asch SM, Adams J et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-45.
2. MacLean CH, Louie R, Leake B et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284: 984-92.
3. Solomon DH, Gabriel SE. A call for evidence-based quality measures: a goal worthy of pursuit. Nat Clin Pract 2007;3: 363.
4. Schmajuk G, Schneeweiss S, Katz JN et al. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007;57: 928-34.
5. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008;46:1459-65.
6. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009*. Ann Intern Med 2009;150:40-4.
7. Saag KG, Teng GG, Patkar NM et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59: 762-84.
8. Sowden E, Mitchell WS. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007;8:58.
9. Pebody RG, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect 2008;136:360-9.
10. Ledwich LJ, Harrington TM, Ayoub WT, Sartorius JA, Newman ED. Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert. Arthritis Rheum 2009;61:1505-10.
11. Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:837-8.
12. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. Br Med J 1998;317:465-8.
13. Greim J, Housman D, Turchin A et al. The quality data warehouse: delivering answers on demand. In: AMIA Annual Symposium Proceedings/AMIA Symposium 2006:934.
14. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72.
15. Altman D. Practical statistics for medical research. London: Chapman & Hall, 1991.
16. Brook RH, McGlynn EA, Cleary PD. Quality of health care. Part 2: measuring quality of care. N Engl J Med 1996;335: 966-70.
17. Weiner M, Quwatli Z, Perkins AJ, Lewis JN, Callahan CM. Limitation of a single clinical data source for measuring physicians' performance on quality indicators. J Am Geriatr Soc 2006;54:1256-60.
18. Kern LM, Dhopeshwarkar R, Barron Y, Wilcox A, Pincus H, Kaushal R. Measuring the effects of health information technology on quality of care: a novel set of proposed metrics for electronic quality reporting. Jt Comm J Qual Patient Saf/Joint Commission Resources 2009;35:359-69.
19. Gluck T. Vaccinate your immunocompromised patients! Rheumatology 2006;45:9-10.
20. Medicine Io. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
21. AHRQ. Quality indicators introduction. 2009, [cited September 2, 2009]; http://www.qualityindicators.ahrq.gov/introduction.htm.
22. Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand SL. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005;45: 1147-56.
23. van Hulst LT, Fransen J, den Broeder AA, Grol R, van Riel PL, Hulscher ME. Development of quality indicators for monitoring of the disease course in rheumatoid arthritis. Ann Rheum Dis 2009;68:1805-10.
24. McGlynn EA. Choosing and evaluating clinical performance measures. Jt Comm J Qual Improv 1998;24:470-9.
25. Rubin HR, Pronovost P, Diette GB. From a process of care to a measure: the development and testing of a quality indicator. Int J Qual Health Care 2001;13:489-96.
26. Agnew-Blais JC, Coblyn JS, Katz JN, Anderson RJ, Mehta J, Solomon DH. Measuring quality of care for rheumatic diseases using an electronic medical record. Ann Rheum Dis 2009;68:680-4.
27. Elkayam O, Paran D, Caspi D et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-53.
28. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008;8:124-8.
29. Brezinschek HP, Hofstaetter T, Leeb BF, Haindl P, Graninger WB. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate. Curr Opin Rheumatol 2008;20:295-9.
30. Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 2007;34:952-7.
31. Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 2006;45:106-11.
32. Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004;33:283-8.
33. Mease PJ, Ritchlin CT, Martin RW et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31: 1356-61.